Newron Pharmaceuticals S.p.A. (NP5.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In EUR
| Market Cap | 526.03M |
| Enterprise Value | 551.98M |
| P/E Ratio | -6 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 17.5 |
| Price/Book Ratio | -15.34 |
| Enterprise/Revenue | 19.71 |
| Enterprise/EBITDA | -9.16 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -2.83 |
| Operating Margin | -2.17 |
| Return On Assets | -0.73 |
| Return On Equity | 2.58 |
| Revenue | 19.13M |
| Revenue/Share | 0.51 |
| Gross Profit | 19.13M |
| EBITDA | -4.55M |
| Net Income | -13.33M |
| Diluted EPS | -0.67 |
| Total Cash | 32.86M |
| Total Cash/Share | 1.61 |
| Total Debt | 39M |
| Total Debt/Equity | -3.34 |
| Current Ratio | 3.15 |
| Book Value Per Share | -0.57 |
| 52-Week Change | -25.98 |
| 52-Week High | 34.65 |
| 52-Week Low | 8.18 |
| Moving Average 50 Days | 12.51 |
| Moving Average 200 Days | 16.84 |
| Average Volume | 5,829 |
| Shares Outstanding | 20.81M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |